A detailed history of Cfm Wealth Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cfm Wealth Partners LLC holds 21,203 shares of ABBV stock, worth $3.82 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares
21,203
Previous 20,264 4.63%
Holding current value
$3.82 Million
Previous $4 Million 4.65%
% of portfolio
0.74%
Previous 0.83%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$163.84 - $199.33 $153,845 - $187,170
939 Added 4.63%
21,203 $4.19 Million
Q3 2024

Oct 15, 2024

SELL
$163.84 - $199.33 $141,066 - $171,623
-861 Reduced 4.08%
20,264 $4 Million
Q2 2024

Jul 18, 2024

BUY
$154.79 - $180.76 $133,274 - $155,634
861 Added 4.25%
21,125 $3.62 Million
Q1 2024

Apr 15, 2024

BUY
$159.82 - $182.1 $153,587 - $174,998
961 Added 4.98%
20,264 $3.69 Million
Q4 2023

Jan 11, 2024

BUY
$137.6 - $154.97 $14,172 - $15,961
103 Added 0.54%
19,303 $2.99 Million
Q3 2023

Oct 11, 2023

BUY
$133.59 - $154.65 $56,775 - $65,726
425 Added 2.26%
19,200 $2.86 Million
Q2 2023

Jul 14, 2023

SELL
$132.51 - $164.9 $10,335 - $12,862
-78 Reduced 0.41%
18,775 $2.53 Million
Q1 2023

Apr 12, 2023

BUY
$144.61 - $166.54 $2.73 Million - $3.14 Million
18,853 New
18,853 $3 Million
Q4 2022

Jan 19, 2023

BUY
$138.31 - $165.87 $12,586 - $15,094
91 Added 0.49%
18,486 $2.99 Billion
Q3 2022

Oct 17, 2022

BUY
$134.21 - $153.93 $360,622 - $413,609
2,687 Added 17.11%
18,395 $2.47 Million
Q2 2022

Jul 12, 2022

BUY
$137.62 - $174.96 $59,727 - $75,932
434 Added 2.84%
15,708 $2.41 Million
Q1 2022

Apr 14, 2022

SELL
$131.98 - $163.75 $32,467 - $40,282
-246 Reduced 1.59%
15,274 $2.48 Million
Q3 2021

Oct 25, 2021

BUY
$106.4 - $120.78 $27,344 - $31,040
257 Added 1.68%
15,520 $1.67 Million
Q2 2021

Jul 21, 2021

BUY
$105.21 - $117.21 $55,340 - $61,652
526 Added 3.57%
15,263 $1.72 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $36,930 - $40,655
361 Added 2.51%
14,737 $1.6 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $18,834 - $25,428
234 Added 1.65%
14,376 $1.54 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $92,525 - $108,593
1,077 Added 8.24%
14,142 $1.24 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $57,668 - $77,169
786 Added 6.4%
13,065 $1.28 Million
Q1 2020

May 12, 2020

BUY
$64.5 - $97.79 $42,054 - $63,759
652 Added 5.61%
12,279 $936,000
Q4 2019

Jan 30, 2020

BUY
$72.13 - $90.25 $838,655 - $1.05 Million
11,627 New
11,627 $1.04 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Cfm Wealth Partners LLC Portfolio

Follow Cfm Wealth Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cfm Wealth Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cfm Wealth Partners LLC with notifications on news.